A Trial of SP2086 With Hepatic Insufficiency

NCT06035406 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: Retagliptin Phosphate Tablet

Sponsor

Jiangsu HengRui Medicine Co., Ltd.